Who Paid My Doc
General - Embolics
Device Embolics
General payments
$48,200
Research payments
$43,000
Through program year 2022, $48,200 in general payments and $43,000 in research payments were reported against General - Embolics (Embolics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $382 | 20 |
| 2022 | Research | $43,000 | 1 |
| 2021 | General | $2,430 | 80 |
| 2020 | General | $41,428 | 612 |
| 2019 | General | $3,960 | 20 |
Breakdown
The top 5 of 17 recipients; each share is of general payments naming this product in 2022.
Each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 7 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
732 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.